Dr. Anuj Goenka, MD
Claim this profileLenox Hill Brain Tumor Center
Area of expertise
Brain Cancer
Anuj Goenka, MD has run 6 trials for Brain Cancer. Some of their research focus areas include:
Glioblastoma
Anuj Goenka, MD has run 5 trials for Glioblastoma. Some of their research focus areas include:
Affiliated Hospitals
Lenox Hill Brain Tumor Center
Northwell Health/Center For Advanced Medicine
Clinical Trials Anuj Goenka, MD is currently running
CAPTEM
for Glioblastoma
The purpose of this study is to evaluate the safety and efficacy of administering the medication capecitabine along with temozolomide when you start your monthly regimen of oral temozolomide for the treatment of your newly diagnosed glioblastoma multiforme (GBM). Capecitabine is an oral chemotherapy that is given to patients with other types of cancer. The study will evaluate whether the dosage of 1500 mg/m2 of capecitabine is tolerable after radiation, when taken along with temozolomide. It will also try to determine if the medication capecitabine helps patients respond to treatment for a longer period of time compared to just temozolomide alone, which is the standard of care.
Recruiting
3 awards
Phase 1 & 2
Cetuximab + Reirradiation
for Brain Cancer
Primary brain tumors are typically treated by surgery, radiation therapy and chemotherapy, either individually or in combination. Present therapies are inadequate, as evidenced by the low 5-year survival rate for brain cancer patients, with median survival at approximately 12 months. Glioma is the most common form of primary brain cancer, afflicting approximately 7,000 patients in the United States each year. These highly malignant cancers remain a significant unmet clinical need in oncology. GBM often has a high expression of EFGR (Epidermal Growth Factor Receptor), which is associated with poor prognosis. Several methods of inhibiting this receptor have been tested, including monoclonal antibodies, vaccines, and tyrosine kinase inhibitors. The investigators hypothesize that in patients with recurring GBM, intracranial superselective intra-arterial infusion of Cetuximab (CTX), at a dose of 250mg/m2 in conjunction with hypofractionated radiation, will be safe and efficacious and prevent tumor progression in patients with recurrent, residual GBM.
Recruiting
3 awards
Phase 2
1 criteria
More about Anuj Goenka, MD
Clinical Trial Related
7 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Anuj Goenka, MD has experience with
- Stereotactic Radiosurgery
- Cetuximab
- Whole-Brain Radiotherapy
- Capecitabine
- Temozolomide
- Cetuximab (Erbitux)
Breakdown of trials Anuj Goenka, MD has run
Brain Cancer
Glioblastoma
Brain Tumor
Brain Metastases
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anuj Goenka, MD specialize in?
Anuj Goenka, MD focuses on Brain Cancer and Glioblastoma. In particular, much of their work with Brain Cancer has involved EGFR positive patients, or patients who are Stage IV.
Is Anuj Goenka, MD currently recruiting for clinical trials?
Yes, Anuj Goenka, MD is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Anuj Goenka, MD has studied deeply?
Yes, Anuj Goenka, MD has studied treatments such as Stereotactic Radiosurgery, Cetuximab, Whole-Brain Radiotherapy.
What is the best way to schedule an appointment with Anuj Goenka, MD?
Apply for one of the trials that Anuj Goenka, MD is conducting.
What is the office address of Anuj Goenka, MD?
The office of Anuj Goenka, MD is located at: Lenox Hill Brain Tumor Center, New York, New York 10075 United States. This is the address for their practice at the Lenox Hill Brain Tumor Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.